Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe.
<h4>Background</h4>Timely knowledge of which influenza vaccine brands are procured and where is of interest to inform site-selection for brand-specific influenza vaccine effectiveness (VE) studies. Vaccine procurement is a key determinant of brand availability. We therefore sought to und...
Main Authors: | Anke L Stuurman, Caterina Rizzo, Mendel Haag |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0248943 |
Similar Items
-
Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
by: Ian McGovern, et al.
Published: (2024-12-01) -
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform
by: Stuurman, AL, et al.
Published: (2023) -
Strategies in recommending influenza vaccination in Europe and US
by: Caterina Rizzo, et al.
Published: (2018-03-01) -
Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States
by: Constantina Boikos, et al.
Published: (2022-09-01) -
Rapid assessment of the reactogenicity of a 2016-2017 seasonal influenza vaccine: results from a feasibility study
by: Anke L. Stuurman, et al.
Published: (2017-02-01)